Investigation into in vitro and in vivo models using intestinal epithelial IPEC‐J2 cells and Caenorhabditis elegans for selecting probiotic candidates to control porcine enterotoxigenic Escherichia coli

AIMS: To identify a fast, economic and reliable method for preselecting lactic acid‐producing bacterial (LAB) isolates to control enterotoxigenic Escherichia coli (ETEC). METHODS AND RESULTS: Two assays with porcine intestinal epithelial IPEC‐J2 cells or Caenorhabditis elegans for selecting effectiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of applied microbiology 2014-07, Vol.117 (1), p.217-226
Hauptverfasser: Zhou, M, Zhu, J, Yu, H, Yin, X, Sabour, P.M, Zhao, L, Chen, W, Gong, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 226
container_issue 1
container_start_page 217
container_title Journal of applied microbiology
container_volume 117
creator Zhou, M
Zhu, J
Yu, H
Yin, X
Sabour, P.M
Zhao, L
Chen, W
Gong, J
description AIMS: To identify a fast, economic and reliable method for preselecting lactic acid‐producing bacterial (LAB) isolates to control enterotoxigenic Escherichia coli (ETEC). METHODS AND RESULTS: Two assays with porcine intestinal epithelial IPEC‐J2 cells or Caenorhabditis elegans for selecting effective probiotic candidates were compared. Both assays were based on measuring death of cells or worms caused by ETEC strain JG280. Six of 13 LAB isolates showed ≥50% protection in each assay, among which only four isolates (≥50% protection) were consistently selected by both assays. Isolate CL9 (Lactobacillus reuteri) was further studied. It reduced gene expression of estA, estB and elt in JG280 in both assays. Furthermore, the isolate protected IPEC‐J2 and C. elegans from cell and worm death caused by STa, STb or LT enterotoxin expressed in E. coli DH5α. CL9 also promoted host defensive responses by decreasing IL‐8 and increasing IL‐10 production in IPEC‐J2 cells and expression of antimicrobial peptide genes clec‐60, clec‐85 in C. elegans. CONCLUSIONS: Caenorhabditis elegans is useful for preselecting probiotic candidates to control ETEC after initial screening with IPEC‐J2 cells. SIGNIFICANCE AND IMPACT OF THE STUDY: A combination of IPEC‐J2 cell and C. elegans assays can improve the effectiveness in preselecting probiotic candidates.
doi_str_mv 10.1111/jam.12505
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1544009745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3334579691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4755-580b6f7664e60475f789cd34770643742e8164dbf3e7679f5df2b8767807a2183</originalsourceid><addsrcrecordid>eNqNks2O0zAQxyMEYj_gwAuAJYQEh-7ajj_S46oq0NUikGDPkeM46VSp3bWTwt72EXgwnoInYdJ2QUJCwgd7bP3mP-OZybJnjJ4xXOcrsz5jXFL5IDtmuZITrjR_uLPFRFLNj7KTlFaUspxK9Tg74kJpIafyOPux8FuXemhND8ET8H3AjWyhj4EYX-8v20DWoXZdIkMC347Y6ORNR9wG-qXrAM3Fp_ns5933S06s65Ad3WfG-RCXpqqhh0Rc51rjE2lCJAkvth_lNjFUEHqwxKIP1AbVCSZig8c0OrIJ0YJ3xGHYGPrwDVrnkZ4nu3QR7BIMsh08yR41pkvu6eE8za7fzr_M3k-uPr5bzC6uJlZoKSeyoJVqtFLCKYovjS6mts6F1lSJXAvuCqZEXTW500pPG1k3vCrQLKg2nBX5afZ6r4uJ3wxYiXINafyz8S4MqWRSCEqnWOL_QHOlCuzTiL78C12FIWKNd5RUNOeSI_VmT9kYUoquKTcR1ibeloyW4zSUOA3lbhqQfX5QHKq1q3-T9-1H4NUBMMmaronGW0h_uALjSjF--HzPfYXO3f47Ynl58eE-9Iu9R2NCadqIqtefOWUSh1BiA1j-C8EP148</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1535603252</pqid></control><display><type>article</type><title>Investigation into in vitro and in vivo models using intestinal epithelial IPEC‐J2 cells and Caenorhabditis elegans for selecting probiotic candidates to control porcine enterotoxigenic Escherichia coli</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Zhou, M ; Zhu, J ; Yu, H ; Yin, X ; Sabour, P.M ; Zhao, L ; Chen, W ; Gong, J</creator><creatorcontrib>Zhou, M ; Zhu, J ; Yu, H ; Yin, X ; Sabour, P.M ; Zhao, L ; Chen, W ; Gong, J</creatorcontrib><description>AIMS: To identify a fast, economic and reliable method for preselecting lactic acid‐producing bacterial (LAB) isolates to control enterotoxigenic Escherichia coli (ETEC). METHODS AND RESULTS: Two assays with porcine intestinal epithelial IPEC‐J2 cells or Caenorhabditis elegans for selecting effective probiotic candidates were compared. Both assays were based on measuring death of cells or worms caused by ETEC strain JG280. Six of 13 LAB isolates showed ≥50% protection in each assay, among which only four isolates (≥50% protection) were consistently selected by both assays. Isolate CL9 (Lactobacillus reuteri) was further studied. It reduced gene expression of estA, estB and elt in JG280 in both assays. Furthermore, the isolate protected IPEC‐J2 and C. elegans from cell and worm death caused by STa, STb or LT enterotoxin expressed in E. coli DH5α. CL9 also promoted host defensive responses by decreasing IL‐8 and increasing IL‐10 production in IPEC‐J2 cells and expression of antimicrobial peptide genes clec‐60, clec‐85 in C. elegans. CONCLUSIONS: Caenorhabditis elegans is useful for preselecting probiotic candidates to control ETEC after initial screening with IPEC‐J2 cells. SIGNIFICANCE AND IMPACT OF THE STUDY: A combination of IPEC‐J2 cell and C. elegans assays can improve the effectiveness in preselecting probiotic candidates.</description><identifier>ISSN: 1364-5072</identifier><identifier>EISSN: 1365-2672</identifier><identifier>DOI: 10.1111/jam.12505</identifier><identifier>PMID: 24674595</identifier><identifier>CODEN: JAMIFK</identifier><language>eng</language><publisher>Oxford: Published for the Society for Applied Bacteriology by Blackwell Science</publisher><subject>Animals ; Antibiosis ; Antimicrobial Cationic Peptides - agonists ; Antimicrobial Cationic Peptides - biosynthesis ; antimicrobial peptides ; Biological and medical sciences ; Caenorhabditis elegans ; Caenorhabditis elegans - drug effects ; Caenorhabditis elegans - microbiology ; Cell Line ; death ; E coli ; enterotoxigenic Escherichia coli ; Enterotoxigenic Escherichia coli - drug effects ; Enterotoxigenic Escherichia coli - growth &amp; development ; enterotoxins ; Enterotoxins - antagonists &amp; inhibitors ; Enterotoxins - biosynthesis ; Epithelial Cells - drug effects ; Epithelial Cells - microbiology ; Escherichia coli ; Escherichia coli Infections - diet therapy ; Escherichia coli Infections - microbiology ; Escherichia coli Infections - veterinary ; Fundamental and applied biological sciences. Psychology ; Gene expression ; genes ; interleukin-10 ; Interleukin-10 - agonists ; Interleukin-10 - metabolism ; interleukin-8 ; Interleukin-8 - antagonists &amp; inhibitors ; Interleukin-8 - metabolism ; Intestines - drug effects ; Intestines - microbiology ; IPEC‐J2 ; lactic acid‐producing bacteria ; Lactobacillus reuteri ; Lactobacillus reuteri - physiology ; Microbiology ; models for selection ; Models, Biological ; Nematodes ; Probiotics ; Probiotics - pharmacology ; screening ; Swine ; Swine Diseases - diet therapy ; Swine Diseases - microbiology</subject><ispartof>Journal of applied microbiology, 2014-07, Vol.117 (1), p.217-226</ispartof><rights>2014 Society for Applied Microbiology and Her Majesty the Queen in Right of Canada Reproduced with the permission of the Minister of Agriculture and Agri‐Food Canada.</rights><rights>2015 INIST-CNRS</rights><rights>2014 Society for Applied Microbiology and Her Majesty the Queen in Right of Canada Reproduced with the permission of the Minister of Agriculture and Agri-Food Canada.</rights><rights>Copyright © 2014 The Society for Applied Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4755-580b6f7664e60475f789cd34770643742e8164dbf3e7679f5df2b8767807a2183</citedby><cites>FETCH-LOGICAL-c4755-580b6f7664e60475f789cd34770643742e8164dbf3e7679f5df2b8767807a2183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjam.12505$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjam.12505$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28535548$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24674595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, M</creatorcontrib><creatorcontrib>Zhu, J</creatorcontrib><creatorcontrib>Yu, H</creatorcontrib><creatorcontrib>Yin, X</creatorcontrib><creatorcontrib>Sabour, P.M</creatorcontrib><creatorcontrib>Zhao, L</creatorcontrib><creatorcontrib>Chen, W</creatorcontrib><creatorcontrib>Gong, J</creatorcontrib><title>Investigation into in vitro and in vivo models using intestinal epithelial IPEC‐J2 cells and Caenorhabditis elegans for selecting probiotic candidates to control porcine enterotoxigenic Escherichia coli</title><title>Journal of applied microbiology</title><addtitle>J Appl Microbiol</addtitle><description>AIMS: To identify a fast, economic and reliable method for preselecting lactic acid‐producing bacterial (LAB) isolates to control enterotoxigenic Escherichia coli (ETEC). METHODS AND RESULTS: Two assays with porcine intestinal epithelial IPEC‐J2 cells or Caenorhabditis elegans for selecting effective probiotic candidates were compared. Both assays were based on measuring death of cells or worms caused by ETEC strain JG280. Six of 13 LAB isolates showed ≥50% protection in each assay, among which only four isolates (≥50% protection) were consistently selected by both assays. Isolate CL9 (Lactobacillus reuteri) was further studied. It reduced gene expression of estA, estB and elt in JG280 in both assays. Furthermore, the isolate protected IPEC‐J2 and C. elegans from cell and worm death caused by STa, STb or LT enterotoxin expressed in E. coli DH5α. CL9 also promoted host defensive responses by decreasing IL‐8 and increasing IL‐10 production in IPEC‐J2 cells and expression of antimicrobial peptide genes clec‐60, clec‐85 in C. elegans. CONCLUSIONS: Caenorhabditis elegans is useful for preselecting probiotic candidates to control ETEC after initial screening with IPEC‐J2 cells. SIGNIFICANCE AND IMPACT OF THE STUDY: A combination of IPEC‐J2 cell and C. elegans assays can improve the effectiveness in preselecting probiotic candidates.</description><subject>Animals</subject><subject>Antibiosis</subject><subject>Antimicrobial Cationic Peptides - agonists</subject><subject>Antimicrobial Cationic Peptides - biosynthesis</subject><subject>antimicrobial peptides</subject><subject>Biological and medical sciences</subject><subject>Caenorhabditis elegans</subject><subject>Caenorhabditis elegans - drug effects</subject><subject>Caenorhabditis elegans - microbiology</subject><subject>Cell Line</subject><subject>death</subject><subject>E coli</subject><subject>enterotoxigenic Escherichia coli</subject><subject>Enterotoxigenic Escherichia coli - drug effects</subject><subject>Enterotoxigenic Escherichia coli - growth &amp; development</subject><subject>enterotoxins</subject><subject>Enterotoxins - antagonists &amp; inhibitors</subject><subject>Enterotoxins - biosynthesis</subject><subject>Epithelial Cells - drug effects</subject><subject>Epithelial Cells - microbiology</subject><subject>Escherichia coli</subject><subject>Escherichia coli Infections - diet therapy</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Escherichia coli Infections - veterinary</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene expression</subject><subject>genes</subject><subject>interleukin-10</subject><subject>Interleukin-10 - agonists</subject><subject>Interleukin-10 - metabolism</subject><subject>interleukin-8</subject><subject>Interleukin-8 - antagonists &amp; inhibitors</subject><subject>Interleukin-8 - metabolism</subject><subject>Intestines - drug effects</subject><subject>Intestines - microbiology</subject><subject>IPEC‐J2</subject><subject>lactic acid‐producing bacteria</subject><subject>Lactobacillus reuteri</subject><subject>Lactobacillus reuteri - physiology</subject><subject>Microbiology</subject><subject>models for selection</subject><subject>Models, Biological</subject><subject>Nematodes</subject><subject>Probiotics</subject><subject>Probiotics - pharmacology</subject><subject>screening</subject><subject>Swine</subject><subject>Swine Diseases - diet therapy</subject><subject>Swine Diseases - microbiology</subject><issn>1364-5072</issn><issn>1365-2672</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks2O0zAQxyMEYj_gwAuAJYQEh-7ajj_S46oq0NUikGDPkeM46VSp3bWTwt72EXgwnoInYdJ2QUJCwgd7bP3mP-OZybJnjJ4xXOcrsz5jXFL5IDtmuZITrjR_uLPFRFLNj7KTlFaUspxK9Tg74kJpIafyOPux8FuXemhND8ET8H3AjWyhj4EYX-8v20DWoXZdIkMC347Y6ORNR9wG-qXrAM3Fp_ns5933S06s65Ad3WfG-RCXpqqhh0Rc51rjE2lCJAkvth_lNjFUEHqwxKIP1AbVCSZig8c0OrIJ0YJ3xGHYGPrwDVrnkZ4nu3QR7BIMsh08yR41pkvu6eE8za7fzr_M3k-uPr5bzC6uJlZoKSeyoJVqtFLCKYovjS6mts6F1lSJXAvuCqZEXTW500pPG1k3vCrQLKg2nBX5afZ6r4uJ3wxYiXINafyz8S4MqWRSCEqnWOL_QHOlCuzTiL78C12FIWKNd5RUNOeSI_VmT9kYUoquKTcR1ibeloyW4zSUOA3lbhqQfX5QHKq1q3-T9-1H4NUBMMmaronGW0h_uALjSjF--HzPfYXO3f47Ynl58eE-9Iu9R2NCadqIqtefOWUSh1BiA1j-C8EP148</recordid><startdate>201407</startdate><enddate>201407</enddate><creator>Zhou, M</creator><creator>Zhu, J</creator><creator>Yu, H</creator><creator>Yin, X</creator><creator>Sabour, P.M</creator><creator>Zhao, L</creator><creator>Chen, W</creator><creator>Gong, J</creator><general>Published for the Society for Applied Bacteriology by Blackwell Science</general><general>Blackwell</general><general>Oxford University Press</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TM</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201407</creationdate><title>Investigation into in vitro and in vivo models using intestinal epithelial IPEC‐J2 cells and Caenorhabditis elegans for selecting probiotic candidates to control porcine enterotoxigenic Escherichia coli</title><author>Zhou, M ; Zhu, J ; Yu, H ; Yin, X ; Sabour, P.M ; Zhao, L ; Chen, W ; Gong, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4755-580b6f7664e60475f789cd34770643742e8164dbf3e7679f5df2b8767807a2183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antibiosis</topic><topic>Antimicrobial Cationic Peptides - agonists</topic><topic>Antimicrobial Cationic Peptides - biosynthesis</topic><topic>antimicrobial peptides</topic><topic>Biological and medical sciences</topic><topic>Caenorhabditis elegans</topic><topic>Caenorhabditis elegans - drug effects</topic><topic>Caenorhabditis elegans - microbiology</topic><topic>Cell Line</topic><topic>death</topic><topic>E coli</topic><topic>enterotoxigenic Escherichia coli</topic><topic>Enterotoxigenic Escherichia coli - drug effects</topic><topic>Enterotoxigenic Escherichia coli - growth &amp; development</topic><topic>enterotoxins</topic><topic>Enterotoxins - antagonists &amp; inhibitors</topic><topic>Enterotoxins - biosynthesis</topic><topic>Epithelial Cells - drug effects</topic><topic>Epithelial Cells - microbiology</topic><topic>Escherichia coli</topic><topic>Escherichia coli Infections - diet therapy</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Escherichia coli Infections - veterinary</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene expression</topic><topic>genes</topic><topic>interleukin-10</topic><topic>Interleukin-10 - agonists</topic><topic>Interleukin-10 - metabolism</topic><topic>interleukin-8</topic><topic>Interleukin-8 - antagonists &amp; inhibitors</topic><topic>Interleukin-8 - metabolism</topic><topic>Intestines - drug effects</topic><topic>Intestines - microbiology</topic><topic>IPEC‐J2</topic><topic>lactic acid‐producing bacteria</topic><topic>Lactobacillus reuteri</topic><topic>Lactobacillus reuteri - physiology</topic><topic>Microbiology</topic><topic>models for selection</topic><topic>Models, Biological</topic><topic>Nematodes</topic><topic>Probiotics</topic><topic>Probiotics - pharmacology</topic><topic>screening</topic><topic>Swine</topic><topic>Swine Diseases - diet therapy</topic><topic>Swine Diseases - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, M</creatorcontrib><creatorcontrib>Zhu, J</creatorcontrib><creatorcontrib>Yu, H</creatorcontrib><creatorcontrib>Yin, X</creatorcontrib><creatorcontrib>Sabour, P.M</creatorcontrib><creatorcontrib>Zhao, L</creatorcontrib><creatorcontrib>Chen, W</creatorcontrib><creatorcontrib>Gong, J</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of applied microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, M</au><au>Zhu, J</au><au>Yu, H</au><au>Yin, X</au><au>Sabour, P.M</au><au>Zhao, L</au><au>Chen, W</au><au>Gong, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigation into in vitro and in vivo models using intestinal epithelial IPEC‐J2 cells and Caenorhabditis elegans for selecting probiotic candidates to control porcine enterotoxigenic Escherichia coli</atitle><jtitle>Journal of applied microbiology</jtitle><addtitle>J Appl Microbiol</addtitle><date>2014-07</date><risdate>2014</risdate><volume>117</volume><issue>1</issue><spage>217</spage><epage>226</epage><pages>217-226</pages><issn>1364-5072</issn><eissn>1365-2672</eissn><coden>JAMIFK</coden><abstract>AIMS: To identify a fast, economic and reliable method for preselecting lactic acid‐producing bacterial (LAB) isolates to control enterotoxigenic Escherichia coli (ETEC). METHODS AND RESULTS: Two assays with porcine intestinal epithelial IPEC‐J2 cells or Caenorhabditis elegans for selecting effective probiotic candidates were compared. Both assays were based on measuring death of cells or worms caused by ETEC strain JG280. Six of 13 LAB isolates showed ≥50% protection in each assay, among which only four isolates (≥50% protection) were consistently selected by both assays. Isolate CL9 (Lactobacillus reuteri) was further studied. It reduced gene expression of estA, estB and elt in JG280 in both assays. Furthermore, the isolate protected IPEC‐J2 and C. elegans from cell and worm death caused by STa, STb or LT enterotoxin expressed in E. coli DH5α. CL9 also promoted host defensive responses by decreasing IL‐8 and increasing IL‐10 production in IPEC‐J2 cells and expression of antimicrobial peptide genes clec‐60, clec‐85 in C. elegans. CONCLUSIONS: Caenorhabditis elegans is useful for preselecting probiotic candidates to control ETEC after initial screening with IPEC‐J2 cells. SIGNIFICANCE AND IMPACT OF THE STUDY: A combination of IPEC‐J2 cell and C. elegans assays can improve the effectiveness in preselecting probiotic candidates.</abstract><cop>Oxford</cop><pub>Published for the Society for Applied Bacteriology by Blackwell Science</pub><pmid>24674595</pmid><doi>10.1111/jam.12505</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1364-5072
ispartof Journal of applied microbiology, 2014-07, Vol.117 (1), p.217-226
issn 1364-5072
1365-2672
language eng
recordid cdi_proquest_miscellaneous_1544009745
source MEDLINE; Access via Wiley Online Library; Oxford University Press Journals All Titles (1996-Current)
subjects Animals
Antibiosis
Antimicrobial Cationic Peptides - agonists
Antimicrobial Cationic Peptides - biosynthesis
antimicrobial peptides
Biological and medical sciences
Caenorhabditis elegans
Caenorhabditis elegans - drug effects
Caenorhabditis elegans - microbiology
Cell Line
death
E coli
enterotoxigenic Escherichia coli
Enterotoxigenic Escherichia coli - drug effects
Enterotoxigenic Escherichia coli - growth & development
enterotoxins
Enterotoxins - antagonists & inhibitors
Enterotoxins - biosynthesis
Epithelial Cells - drug effects
Epithelial Cells - microbiology
Escherichia coli
Escherichia coli Infections - diet therapy
Escherichia coli Infections - microbiology
Escherichia coli Infections - veterinary
Fundamental and applied biological sciences. Psychology
Gene expression
genes
interleukin-10
Interleukin-10 - agonists
Interleukin-10 - metabolism
interleukin-8
Interleukin-8 - antagonists & inhibitors
Interleukin-8 - metabolism
Intestines - drug effects
Intestines - microbiology
IPEC‐J2
lactic acid‐producing bacteria
Lactobacillus reuteri
Lactobacillus reuteri - physiology
Microbiology
models for selection
Models, Biological
Nematodes
Probiotics
Probiotics - pharmacology
screening
Swine
Swine Diseases - diet therapy
Swine Diseases - microbiology
title Investigation into in vitro and in vivo models using intestinal epithelial IPEC‐J2 cells and Caenorhabditis elegans for selecting probiotic candidates to control porcine enterotoxigenic Escherichia coli
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A35%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigation%20into%20in%20vitro%20and%20in%20vivo%20models%20using%20intestinal%20epithelial%20IPEC%E2%80%90J2%20cells%20and%20Caenorhabditis%20elegans%20for%20selecting%20probiotic%20candidates%20to%20control%20porcine%20enterotoxigenic%20Escherichia%20coli&rft.jtitle=Journal%20of%20applied%20microbiology&rft.au=Zhou,%20M&rft.date=2014-07&rft.volume=117&rft.issue=1&rft.spage=217&rft.epage=226&rft.pages=217-226&rft.issn=1364-5072&rft.eissn=1365-2672&rft.coden=JAMIFK&rft_id=info:doi/10.1111/jam.12505&rft_dat=%3Cproquest_cross%3E3334579691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1535603252&rft_id=info:pmid/24674595&rfr_iscdi=true